MMRII

Description

M-M-R II (Measles, Mumps, and Rubella Virus Vaccine Live) is a live virus vaccine for vaccination against measles (rubeola), mumps, and rubella (German measles).

M-M-R II is a sterile lyophilized preparation of attenuated line of measles virus strain propagated in chick embryo cell culture; mumps virus strain propagated in chick embryo cell culture; and rubella virus strain propagated in human diploid lung fibroblasts.

Immunization guideline:

Individuals first vaccinated at 12 months of age or older should be re-vaccinated prior to elementary school entry. 0.5 ml dose of vaccine  should be administered by deep subcutaneous injection into the anterolateral aspect of upper thigh in toddlers and upper arm in older children.

For latest IAP updates see revised immunization schedule.

Additional information

vaccine-type

Measles, Mumps and Rubella

manufacturer

Merck Sharp & Dohme Corp

country-of-manufacture

USA

pharmaceutical-form

Lyophilized

package-size

1 Dose

route-of-administration

Intramuscular

preservative

None

contraindications

Pregnancy, hypersensitivity to any components of the vaccine including gelatin, acute severe febrile illness and impaired immune response. The presence of a minor infection, however, is not a contrain